Lataa...
Transfection of hPSC-Cardiomyocytes Using Viafect™ Transfection Reagent
Twenty years since their first derivation, human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) have shown promise in disease modelling research, while their potential for cardiac repair is being investigated. However, low transfection efficiency is a barrier to wider realisation of the pot...
Tallennettuna:
| Julkaisussa: | Methods Protoc |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7564709/ https://ncbi.nlm.nih.gov/pubmed/32784848 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/mps3030057 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|